- Home
- HAFN vs BHC Comparison
HAFN vs BHC Comparison
Compare HAFN & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFN
- BHC
- Stock Information
- Founded
- HAFN 2012
- BHC N/A
- Country
- HAFN Singapore
- BHC Canada
- Employees
- HAFN N/A
- BHC N/A
- Industry
- HAFN
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- HAFN
- BHC Health Care
- Exchange
- HAFN Nasdaq
- BHC Nasdaq
- Market Cap
- HAFN 2.7B
- BHC 2.4B
- IPO Year
- HAFN N/A
- BHC N/A
- Fundamental
- Price
- HAFN $6.02
- BHC $6.38
- Analyst Decision
- HAFN Strong Buy
- BHC Hold
- Analyst Count
- HAFN 1
- BHC 2
- Target Price
- HAFN $6.50
- BHC $9.00
- AVG Volume (30 Days)
- HAFN 1.1M
- BHC 1.7M
- Earning Date
- HAFN 11-26-2025
- BHC 10-29-2025
- Dividend Yield
- HAFN 10.54%
- BHC N/A
- EPS Growth
- HAFN N/A
- BHC N/A
- EPS
- HAFN 0.84
- BHC 0.27
- Revenue
- HAFN $2,354,657,000.00
- BHC $9,858,000,000.00
- Revenue This Year
- HAFN N/A
- BHC $6.28
- Revenue Next Year
- HAFN N/A
- BHC $3.76
- P/E Ratio
- HAFN $7.10
- BHC $24.09
- Revenue Growth
- HAFN N/A
- BHC 7.13
- 52 Week Low
- HAFN $3.61
- BHC $4.25
- 52 Week High
- HAFN $7.50
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- HAFN 47.86
- BHC 38.57
- Support Level
- HAFN $5.98
- BHC $6.40
- Resistance Level
- HAFN $6.37
- BHC $6.81
- Average True Range (ATR)
- HAFN 0.12
- BHC 0.18
- MACD
- HAFN -0.03
- BHC -0.02
- Stochastic Oscillator
- HAFN 11.25
- BHC 5.00
About HAFN Hafnia Limited Common Shares
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.